---
document_datetime: 2023-09-21 19:16:35
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/telzir-epar-all-authorised-presentations_en.pdf
document_name: telzir-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7691791
conversion_datetime: 2025-12-26 13:03:09.513687
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU number       | Invented name   | Strength   | Pharmaceutical form   | Route of administration   | Packaging     | Content   | Package size                    |
|-----------------|-----------------|------------|-----------------------|---------------------------|---------------|-----------|---------------------------------|
| EU/1/04/282/001 | Telzir          | 700 mg     | Film-coated tablets   | Oral use                  | Bottle (HDPE) |           | 60 tablets                      |
| EU/1/04/282/002 | Telzir          | 50 mg/ml   | Oral suspension       | Oral use                  | Bottle (HDPE) | 225 ml    | 1 bottle + 10 ml dosing syringe |